산소공급기 - 세계 시장 인사이트, 경쟁 상황 및 시장 예측(2030년)

Oxygenators Market By Product Type (Bubble Oxygenator And Membrane Oxygenator), By Application (Respiratory, Cardiac, And Extracorporeal Cardiopulmonary Resuscitation [Ecpr]), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of chronic diseases like respiratory diseases and cardiovascular diseases (cvd) due to unhealthy lifestyle, aging, obesity, and the rising number of geriatric patients across the globe

The global oxygenators market was valued at USD 214.55 million in 2023, growing at a CAGR of 7.45% during the forecast period from 2024 to 2030 to reach USD 329.67 million by 2030. The increase in demand for oxygenators is primarily attributed to the rising prevalence of chronic diseases like respiratory diseases and cardiovascular diseases (CVD). Further, the rising number of geriatric patients, unhealthy eating habits, sedentary lifestyle, obesity, and tobacco & alcohol consumption, thereby increasing the product demand in the market. Furthermore, the surging cases of COVID-19 globally have escalated the product demand in the market as the oxygenators were in high demand during the peak time of the pandemic. Additionally, advancements in the medical oxygenator device such as portability, and customization of flow rate across the world are anticipated to bolster the market, thereby contributing to the overall growth of the oxygenators market during the forecast period from 2024-2030.

Oxygenators Market Dynamics:

The oxygenators market is witnessing a growth in product demand owing to various reasons. The rising prevalence of respiratory and cardiovascular disorders worldwide due to various factors such as high-calorie intake, high sugar intake, sedentary lifestyle, increased intake of processed and packed food, and others are anticipated to bolster the market of oxygenators. Moreover, the increasing number of geriatric patients prone to chronic disorders ultimately propels the growth of the oxygenators market.

For instance, according to World Health Organization (WHO) 2022, Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of death worldwide. Oxygen therapy is needed for COPD patients to control the dropped oxygen level. The mortality rate from COPD can be controlled or reduced by providing proper care at the time of emergency. The devices such as oxygenators can be used to manage COPD attacks, thereby increasing the demand for the device in the market. Further, according to the Burden of Obstructive Lung Disease (BOLD) report, 2020, COPD is expected to rise over the next 40 years and by 2060 there may be more than 5.4 million deaths annually due to COPD. Additionally, according to the American Lung Association (2023), it was estimated that in the year 2019, nearly 52% of people globally reported the symptoms or presence of COPD. Moreover, as per the same source, around 8.5 million adults globally were diagnosed with COPD in the year 2019 - 2020. The increasing prevalence and mortality can be controlled by providing proper treatment which includes proper oxygen supply through an external source. Thus, the increasing prevalence of respiratory disorders such as COPD will increase the demand for oxygenators. Therefore, the increasing demand for the device will propel the overall market growth of oxygenators in the market during the forecast period from 2022 - 2028.

Additionally, the prevalence of heart failure is also rising. For instance, according to Global Health Data Exchange 2019, it was estimated that globally 64.37 million people were suffering from heart failure in the year 2019. In heart failure oxygen is provided through an external device as the heart is not able to provide proper oxygen to the body. Thus, the increasing prevalence of cardiovascular disorders such as heart failure will increase the demand for oxygenators, thereby anticipated to bolster the overall market growth during the forecast period from 2022 - 2028.

Thus, the increasing prevalence of respiratory and cardiovascular disorders globally will drive the rising demand for oxygenators, in turn increasing the oxygenator's market growth.

However, the high cost of the device and treatment and the stringent regulatory process for the approval of the device may also pose a challenge to the oxygenator's market growth.

The market witnessed a COVID-19 outbreak which extensively prompted the use of oxygenators. People who have COVID-19 were at higher risk for pneumonia and hypoxemia, which are major predictors of mortality. People with these complications were recommended proper oxygen supply. This supply can be given by oxygenators, which resulted in the increased demand for oxygenators during the pandemic. Additionally, people suffering from severe viral infection needed oxygen supply through external sources such as oxygenators. Moreover, the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape post-pandemic made the resumption of regular healthcare services, which will keep a steady demand for these products in the market. Thus, creating a somewhat positive impact on the market.

Oxygenators Market Segment Analysis:

Oxygenators Market by Product Type (Bubble Oxygenator and Membrane Oxygenator), Application (Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation [ECPR]), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the oxygenators market, membrane oxygenators are estimated to hold a significant revenue share in the oxygenators market in the year 2023. This can be ascribed to the various advantages that are associated with the product.

Membrane oxygenators are useful in providing required oxygen to a patient's tissues. For instance, in some heart disorders, membrane oxygenators are used such as in acute myocardial infarction, decompensated cardiomyopathy, myocarditis, sepsis, and hypothermia. The growing prevalence of cardiopulmonary disorders is anticipated to drive the demand for membrane oxygenators over the study period. For instance, according to the latest data published by CDC 2022, it is estimated that in the United States, someone has a heart attack every 40 seconds. Moreover, every year, about 805,000 people in the United States suffer from a heart attack.

Additionally, membrane oxygenators are also used in procedures related to pulmonary conditions, such as acute respiratory distress syndrome, COVID-19, pulmonary embolism, and influenza. They are also used in the management of respiratory diseases such as bronchiectasis, hypersensitivity pneumonitis, lung fibrosis, asthma, chronic obstructive pulmonary disease (COPD), lung cancer, and others.

Furthermore, they have wide applications and are used for the treatment of neonates, pediatric patients, and adults. In addition, membrane oxygenators in extracorporeal membrane oxygenation (ECMO) devices provide extracorporeal life support to patients suffering from severe cardiopulmonary disorders.

Moreover, the membrane oxygenator provides various advantages such as better platelet function, higher platelet numbers, and lower hemolysis properties as compared to the bubble oxygenator. Thus, the advantages of membrane oxygenators are expected to drive overall market growth.

Further, membrane oxygenators are used for long-term support in the treatment of acute respiratory failure owing to the improvement in mass transfer efficiency and membrane technology of the oxygenator, driving the market growth during the forecast period from 2022 - 2028.

Thus, owing to the various advantages of the product membrane oxygenators, there will be an increase in the demand for the device, which in turn will drive the overall oxygenator market growth.

North America is expected to dominate the overall Oxygenators Market:

Among all the regions, North America is expected to account for a significant revenue share of the global oxygenators market.

Factors such as the growing prevalence of various respiratory ailments like COPD, hypoxia, and others, the increasing prevalence of geriatric and bedridden patients, increase in air pollution and smoking are some of the key factors which are expected to aid in the growth of oxygenators in the North America market. Further, the increasing spread of coronavirus skyrocketed the demand for the device and is anticipated to increase in the same manner during the forecast period.

For instance, according to the WHO 2022, (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019, in the United States. The mortality rate can be reduced by giving emergency aid to serious patients by providing oxygen supply through oxygenators to the patient, thereby increasing the demand for the device in the market. Furthermore, as per the Centers for Disease Control and Prevention (CDC) 2022, COPD makes breathing difficult for 16 million Americans. The difficulty in breathing can be managed by providing the oxygen supply through a device like oxygenators to the patients, thereby driving the market in North America.

Moreover, according to the American Lung Association (2023), it was estimated that in the year 2019, 16.4 million people in the United States, were suffering from COPD. The increase in the prevalence of chronic respiratory disease will increase the demand for oxygenators as they provide oxygen and carbon dioxide exchange in the blood of a human patient during the attack of respiratory or cardiovascular diseases. Thus, the above factor is anticipated to propel the overall market of the device in the region.

Moreover, according to CDC, in 2020, preterm birth affected 1 of every 10 infants born in the United States. In preterm birth, organs like lungs, heart, and brain may not be fully developed. If the lungs are not developed properly then an external source is used to provide oxygen to the baby. Oxygenators can be used to provide oxygen in the above case. The prevalence is expected to rise at a significant rate during the forecast period. Thus, the burgeoning cases of premature births will contribute to the growth of the oxygenators market.

Furthermore, various organization is working to increase awareness about the symptoms, early diagnosis, treatment, and management of the disease in the region. This activity of the government may increase the demand for disease management through devices such as oxygenators in the market, thereby fostering the market growth of oxygenators in North America.

Therefore, the rising prevalence of respiratory disorders in North America would result in the rising demand for treatments that make use of oxygenators, which in turn would provide a conducive growth environment for the oxygenators market in the North American region.

Hence, the interplay of various factors such as the presence of a large respiratory ailment patient population, increased prevalence of preterm births in the region as well as awareness created among the patients by government and organizations is expected to boost the North America oxygenators market during the forecast period.

Oxygenators Market Key Players:

Some of the key market players operating in the oxygenators market include Chalice Medical Ltd., EUROSETS, Getinge AB., LivaNova PLC, Medtronic, Kewei Medical, Terumo Europe NV, Braile Biomedica, XENIOS AG, Fresenius Medical Care AG & Co. KGaA, MC3 Cardiopulmonary, Gen World Medical Devices., MERA, Owgels, NIPRO Medical Corporation, among others.

Recent Developmental Activities in the Oxygenators Market:

In May 2022, Oxygen Plus (O+), the pioneer and leader in portable canisters of recreational oxygen, announced that the company has completed the acquisition of California-based recreational oxygen company, O2 Naked Air. The agreement corresponded to the growing trend for the nascent category.

In August 2020, Terumo Cardiovascular, a global leader in cardiovascular surgery technologies, and CytoSorbents Corporation, manufacturer of the CytoSorb® extracorporeal cytokine adsorber, announced a collaboration to exclusively sell CytoSorb to hospitals in ten U.S. COVID-19 hotspot. The product is useful for providing oxygen exchange in critically ill adults from COVID-19.

In January 2019, Terumo Cardiovascular Group, a global leader in cardiovascular surgery technologies, announced the launch of its smallest full-size adult oxygenator, the Capiox® NX19 Oxygenator with UltraPrime(TM) Technology.

Key Takeaways from the Oxygenators Market Report Study

• Market size analysis for current oxygenators market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the oxygenators market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the global oxygenators market.
• Various opportunities available for the other competitor in the oxygenators market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current oxygenator's market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for oxygenators market growth in the coming future?

Target Audience who can be benefited from this Oxygenators Market Report Study

• Oxygenators products providers
• Research organizations and consulting companies
• Oxygenators-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in oxygenators
• Various End-users who want to know more about the oxygenators market and latest technological developments in the oxygenators market.

Frequently Asked Questions for Oxygenators Market:

1. What are oxygenators?

An oxygenator is a medical device that is capable of exchanging oxygen and carbon dioxide in the blood of a human patient during surgical procedures that may necessitate the interruption or cessation of blood flow in the body, a critical organ, or a great blood vessel.

2. What is the market for Global oxygenators?

The global oxygenators market was valued at USD 214.55 million in 2023, growing at a CAGR of 7.45% during the forecast period from 2024 to 2030 to reach USD 329.67 million by 2030.

3. What are the drivers for the Global oxygenators market?

The oxygenators market is witnessing positive market growth owing to the increasing prevalence of chronic diseases like respiratory diseases and cardiovascular diseases (CVD) and the rising number of geriatric patients. Moreover, the surging cases of COVID-19 globally have increased the product demand in the market. Additionally, advancements in the medical oxygenator device such as portability, and customization of flow in the devices are anticipated to bolster the market.

4. Who are the key players operating in the Global oxygenators market?

Some of the key market players operating in the oxygenators market include Chalice Medical Ltd., EUROSETS, Getinge AB., LivaNova PLC, Medtronic, Kewei Medical, Terumo Europe NV, Braile Biomedica, XENIOS AG, Fresenius Medical Care AG & Co. KGaA, MC3 Cardiopulmonary, Gen World Medical Devices., MERA, Owgels, NIPRO Medical Corporation, and others.

5. Which region has the highest share in the oxygenators market?

North America is expected to hold the highest share in the revenue in the oxygenators market during the forecast period. The increasing prevalence of chronic diseases like respiratory diseases and cardiovascular diseases (CVD) due to unhealthy lifestyles, age, obesity, and others. Further, the rising number of geriatric patients will also increase the demand for oxygenators in North America, leading to a rise in the overall oxygenator market growth in this region.

Table of Contents

1.Oxygenators Market Report Introduction

2.Oxygenators Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Oxygenators Market Key Factors Analysis

• 4.1. Oxygenators Market Drivers
  • 4.1.1. Increasing prevalence of chronic diseases like respiratory diseases and cardiovascular diseases (CVD)
  • 4.1.2. Surging cases of COVID-19
  • 4.1.3. Rising number of geriatric patients
  • 4.1.4. Advancement in the medical oxygenator device
• 4.2. Oxygenators Market Restraints and Challenges
  • 4.2.1. High cost of oxygenation treatment
  • 4.2.2. Stringent regulatory process
• 4.3. Oxygenators Market Opportunities
  • 4.3.1. Increasing demand for portable oxygenators

5. Oxygenators Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Oxygenators Market

7. Oxygenators Market Layout

• 7.1. By Product Type
  • 7.1.1. Bubble Oxygenator
  • 7.1.2. Membrane Oxygenator
• 7.2. By Application
  • 7.2.1. Respiratory
  • 7.2.2. Cardiac
  • 7.2.3. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
• 7.3. By Geography
  • 7.4.1. North America
    • 7.4.1.1. United States Oxygenators Market Size in USD Million (2021-2030)
    • 7.4.1.2. Canada Oxygenators Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Oxygenators Market Size in USD million (2021-2030)
  • 7.4.2. Europe
    • 7.4.2.1. France Oxygenators Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Oxygenators Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Oxygenators Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Oxygenators Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Oxygenators Market Size in USD million (2021-2030)
    • 7.4.2.6. Russia Oxygenators Market Size in USD million (2021-2030)
    • 7.4.2.7. Rest of Europe Oxygenators Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. China Oxygenators Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Oxygenators Market Size in USD million (2021-2030)
    • 7.4.3.3. India Oxygenators Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Oxygenators Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Oxygenators Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of Asia Pacific Oxygenators Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. Middle East Oxygenators Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Oxygenators Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Oxygenators Market Size in USD million (2021-2030)

8. Oxygenators Market Global Company Share Analysis - Key 3-5 Companies

9. Oxygenators Market Company and Product Profiles

• 9.1. Chalice Medical Ltd.
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. EUROSETS
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Getinge AB.
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. LivaNova PLC
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Medtronic
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. Kewei Medical
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. Terumo Europe NV
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. Braile Biomedica
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. XENIOS AG
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Fresenius Medical Care AG & Co. KGaA
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. MC3 Cardiopulmonary
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Gen World Medical Devices.
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. MERA
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Owgels
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. NIPRO Medical Corporation
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us